# Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial

> **NCT04273256** · PHASE2,PHASE3 · UNKNOWN · sponsor: **American University of Beirut Medical Center** · enrollment: 226 (estimated)

## Conditions studied

- Poor Ovarian Response

## Interventions

- **DRUG:** Myo-inositol

## Key facts

- **NCT ID:** NCT04273256
- **Lead sponsor:** American University of Beirut Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-11
- **Primary completion:** 2022-02
- **Final completion:** 2023-02
- **Target enrollment:** 226 (ESTIMATED)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04273256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04273256, "Myo-inositol for the Management of Poor Ovarian Responders: A Prospective Randomized Controlled Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04273256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*